Over 45,000 corneal transplant eye surgeries are performed in the US every year. On June 12, 2012, in an effort to standardize this complex procedure, two video articles describing pre-surgical preparation of corneal tissue were published in JoVE, the …
Category: News
Vision Problems In Children Born Preterm – What Are The Risk Factors?
Visual impairment in extremely preterm children is mainly due to Retinopathy Of Prematurity (ROP), although cerebral damage, often referred to as cerebral visual impairment, can also be a cause amongst those born extremely premature…
Do Glaucoma Patients Benefit From Telephone Intervention?
In the U.S., over 2 million adults over 40 suffer from glaucoma, and whilst it is possible to reduce the visual field loss of this progressive disease with medication, it is vital to go for regular medical check-ups. Non-adherence of sticking to the m…
Thiazolidinedione Raises Diabetic Macular Edema
According to a report published Online First in Archives of Internal Medicine, glucose-lowering thiazolidinedione drug therapies in patients with Type 2 diabetes seem to be linked to a higher risk of diabetic macular edema (DME) after 1 and 10-year fo…
Drug Combo Shines for Eye Condition
(MedPage Today) — Two angiogenesis targets are better than one for drug therapy in age-related macular degeneration, results of an industry-sponsored study suggested.
Ophthotech’s Fovista anti-PDGF combination therapy superior to Lucentis for wet AMD
Ophthotech Corporation today announced results from the first clinical trial to show statistically significant superior efficacy over Lucentis (ranibizumab) monotherapy for the treatment of neovascular age-related macular degeneration (wet AMD).
Telephone intervention improves medication adherence in patients with glaucoma
A telephone intervention trial was associated with improvement in glaucoma medication adherence in both the treatment group and the control group but, when the two groups were compared, interactive telephone calls and tailored print materials did not s…
Experiences Of People With Long-Term Type 1 Diabetes To Benefit Others
Researchers at Joslin Diabetes Center, supported by JDRF, have completed a study of 158 people who have lived with type 1 diabetes (T1D) for 50 years or more with eye examinations at Joslin over many decades of follow-up, and have concluded that a high…
Viewpoints: Praise for insurers’ move to keep consumer protections; Supreme Court’s reputation falters
UnitedHealthcare, one of the nation’s largest health insurers, announced this week that it would keep some of the popular benefits and consumer protections required by the federal health care law even if the Supreme Court strikes down all or part of it…
Cerebral damage, ROP may increase risk of visual impairment in extremely preterm children
Cerebral damage and retinopathy of prematurity appear to be independently associated with visual impairment among preschool children who were born extremely premature, according to a report published Online First by Archives of Ophthalmology, a JAMA Ne…
Vision Trouble in Preemies Tied to Brain Damage (CME/CE)
(MedPage Today) — A global developmental deficit — an indicator of cerebral damage — may be the primary risk factor for visual impairment in children born extremely premature, a Danish study showed.
Genetic Testing For Color Vision Makes Commercial Debut for Military Applications
Possibly heralding a new era in the use of genetic testing for hiring decisions, Genevolve (Albuquerque, NM) announced at the recent Aerospace Medicine Association conference in Atlanta, GA a new “military grade” test for inherited colo…
System Boosts Glaucoma Compliance (CME/CE)
(MedPage Today) — An automated and interactive program of telephone calls improved adherence to glaucoma treatment in a randomized trial but so did usual care, researchers reported.
RVO advances PresbyLens into final phase of trial for treatment of presbyopia
ReVision Optics, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, announces the advancement of its proprietary product PresbyLens into the final phase of its U.S. clinical trial under an Investigational Device Exemption
Thiazolidinediones: Do They Increase Risk for Macular Edema?
A large retrospective study suggests that patients with type 2 diabetes mellitus who take thiazolidinediones are at increased risk for macular edema, but other experts say more data are needed. Medscape Medical News
Avandia, Actos May Raise Risk of Macular Edema (CME/CE)
(MedPage Today) — The diabetes drugs pioglitazone (Actos) and rosiglitazone (Avandia) appear to substantially boost the risk of macular edema in type 2 disease, an observational study found.
Eyejusters Self-Adjusting Glasses Ready for Distribution to Developing Nations
According to the World Health Organization, 670 million people go about their daily lives with uncorrected vision because they can’t get the glasses they need. Used eyeglasses are commonly donated to developing countries, but with an estimated on…
Potential For Stroke Prevention At The Opticians
A simple eye test may someday offer an effective way to identify patients who are at high risk for stroke, say researchers at the University of Zurich. They showed that a test called ocular pulse amplitude (OPA) can reliably detect carotid artery steno…
Bevacizumab, Dexamethosone Evaluated for CRVO
Findings suggest clinicians continue to refine their approach to macular edema related to central and branch retinal vein occlusion. Medscape Medical News
Fish Oil Prevents Age-Related Loss Of Vision
Loss of vision due to age can potentially be prevented by DHA, an omega-3 fatty acid found in fish. The study, which was recently published in the peer-reviewed journal Investigative Ophthalmology & Visual Science demonstrated that lab models fed with…